dc.creator | David, Romain | es |
dc.creator | Dumas, Alexis | es |
dc.creator | Ojardias, Etienne | es |
dc.creator | Duval, Solène | es |
dc.creator | Ounajim, Amine | es |
dc.creator | Perrochon, Anaïck | es |
dc.creator | Luque Moreno, Carlos | es |
dc.creator | Moens, Maarten | es |
dc.creator | Goudman, Lisa | es |
dc.creator | Rigoard, Philippe | es |
dc.creator | Billot, Maxime | es |
dc.date.accessioned | 2024-05-06T15:08:30Z | |
dc.date.available | 2024-05-06T15:08:30Z | |
dc.date.issued | 2024 | |
dc.identifier.citation | David, R., Dumas, A., Ojardias, E., Duval, S., Ounajim, A., Perrochon, A.,...,Billot, M. (2024). Virtual Reality for Decreasing Procedural Pain during Botulinum Toxin Injection Related to Spasticity Treatment in Adults: A Pilot Study. Medicina-Lithuania, 60 (1), 23. https://doi.org/10.3390/medicina60010023. | |
dc.identifier.issn | 1010-660X | es |
dc.identifier.issn | 1648-9144 | es |
dc.identifier.uri | https://hdl.handle.net/11441/157718 | |
dc.description.abstract | Background and Objectives: Botulinum toxin injections are commonly used for the treat ment of spasticity. However, injection procedures are associated with pain and procedural anxiety.
While pharmacological approaches are commonly used to reduce these, innovative technology might
be considered as a potential non-pharmacological alternative. Given this context, immersive virtual
reality (VR) has shown effectiveness in the management of procedural pain. Our retrospective pilot
study aimed to assess the potential added value of virtual reality in the management of pain and
anxiety during intramuscular injections of botulinum toxin. Materials and Methods: Seventeen adult
patients receiving botulinum toxin injections were included. A numerical rating scale was used to
assess pain and anxiety during the injection procedure. The patients reported the pain experienced
during previous injections without VR before injection and the pain experienced in the current proce dure with VR after the end of the procedure. The level of satisfaction of VR experience, whether or not
they agreed to reuse VR for the subsequent toxin botulinum injection, and whether or not they would
recommend VR to other patients were assessed. Results: The use of virtual reality led to a decrease of
1.8 pain-related points compared to the procedure without technology. No significant improvement
in the level of anxiety was reported. Patients were very satisfied with their VR experiences (7.9 out of
10), and many would agree to reuse VR in their next injection procedure (88%) and to recommend the
use of VR in other patients (100%). Conclusion: VR was useful for managing procedural pain related
to botulinum toxin injection in adults, with a high level of satisfaction reported by the patients. VR
should be considered as a valuable alternative to pharmacological approaches to manage procedural
pain during botulinum toxin injection in adults. | es |
dc.format | application/pdf | es |
dc.format.extent | 11 p. | es |
dc.language.iso | eng | es |
dc.publisher | MDPI | es |
dc.relation.ispartof | Medicina-Lithuania, 60 (1), 23. | |
dc.rights | Atribución 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | Central nervous system disease | es |
dc.subject | Complementary therapies | es |
dc.subject | Virtual reality | es |
dc.subject | Pain | es |
dc.subject | Anxiety | es |
dc.title | Virtual Reality for Decreasing Procedural Pain during Botulinum Toxin Injection Related to Spasticity Treatment in Adults: A Pilot Study | es |
dc.type | info:eu-repo/semantics/article | es |
dc.type.version | info:eu-repo/semantics/publishedVersion | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.contributor.affiliation | Universidad de Sevilla. Departamento de Fisioterapia | es |
dc.contributor.affiliation | Instituto de Biomedicina de Sevilla (IBIS) | |
dc.relation.publisherversion | https://www.mdpi.com/1648-9144/60/1/23 | es |
dc.identifier.doi | 10.3390/medicina60010023 | es |
dc.contributor.group | Universidad de Sevilla. CTS1137: Neurological Physiotherapy, Innovative Neurorehabilitation and Neurodevelopment Disorders. | es |
dc.journaltitle | Medicina-Lithuania | es |
dc.publication.volumen | 60 | es |
dc.publication.issue | 1 | es |
dc.publication.initialPage | 23 | es |